Compound details
Oxidized glutathione
| Compound ID | CDAMM02905 |
|---|---|
| Common name | Oxidized glutathione | IUPAC name | 2-amino-5-[[3-[[2-[(4-amino-4-carboxybutanoyl)amino]-3-(carboxymethylamino)-3-oxopropyl]disulfanyl]-1-(carboxymethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid |
| Molecular formula | C20H32N6O12S2 |
| Retention time | 15.1 |
|---|---|
| Adduct | [M+K]+ |
| Actual mz | 651.107 | Theoretical mz | 651.115 |
| Error | 12.99 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.0715 |
| Inchi key | YPZRWBKMTBYPTK-UHFFFAOYNA-N |
|---|---|
| Smiles | O=C(O)CNC(=O)C(NC(=O)CCC(N)C(=O)O)CSSCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O |
| Superclass | Organic acids and derivatives |
| Class | Carboxylic acids and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P35228 | NOS2 | Nitric oxide synthase, inducible | T02703 | SEA |
| P09960 | LTA4H | Leukotriene A4 hydrolase | T03691 | SEA |
| O00222 | GRM8 | Metabotropic glutamate receptor 8 | T77548 | SEA |
| P08514 | ITGA2B | Integrin alpha-IIb/beta-3 | T50688 | SEA |
| P43005 | SLC1A1 | Excitatory amino acid transporter 3 | T31721 | SEA |
| O15303 | GRM6 | Metabotropic glutamate receptor 6 | T55956 | SEA |
| P04035 | HMGCR | HMG-CoA reductase | T53585 | SEA |
| P09211 | GSTP1 | Glutathione S-transferase Pi | T21669 | SEA |
| P08263 | GSTA1 | Glutathione S-transferase A1 | T17221 | SEA |
| P04439 | HLA-A | HLA class I histocompatibility antigen A-3 | T08985 | SEA |
| Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | T30219 | SEA |
| Q9Y3Q0 | NAALAD2 | NAALADase II | T70036 | SEA |
| Q92820 | GGH | Gamma-glutamyl hydrolase | T71646 | SEA |
| Q04760 | GLO1 | Glyoxalase I | T88285 | SEA |
| P09210 | GSTA2 | Glutathione S-transferase A2 | T53510 | SEA |
| Q04609 | FOLH1 | Glutamate carboxypeptidase II | T97071 | SEA |
| Q9Y4G9 | PCSK6 | Proprotein convertase subtilisin/kexin type 6 | T86503 | SEA |
| P05106 | ITGB3 | Integrin beta-3 | T26457 | SEA |
| P00480 | OTC | Ornithine transcarbamylase | T52098 | SEA |
| Q16348 | PEPT2 | Solute carrier family 15 member 2 | T52067 | SEA |
| Q92887 | CMOAT | Multidrug resistance-associated protein 2 | T61792 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T02703 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P35228 | NOS2 |
| T02703 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P35228 | NOS2 |
| T02703 | DI0375 | Sepsis | [ICD-11: 1G40-1G41] | P35228 | NOS2 |
| T02703 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P35228 | NOS2 |
| T03691 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P09960 | LTA4H |
| T50688 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P08514 | ITGA2B |
| T50688 | DI0030 | Angina pectoris | [ICD-11: BA40] | P08514 | ITGA2B |
| T50688 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P08514 | ITGA2B |
| T53585 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P04035 | HMGCR |
| T53585 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P04035 | HMGCR |
| T53585 | DI0128 | Dyslipidemia | [ICD-11: 5C80-5C81] | P04035 | HMGCR |
| T53585 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P04035 | HMGCR |
| T53585 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P04035 | HMGCR |
| T53585 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P04035 | HMGCR |
| T53585 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P04035 | HMGCR |
| T21669 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P09211 | GSTP1 |
| T88285 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | Q04760 | GLO1 |
| T97071 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | Q04609 | FOLH1 |
| T97071 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q04609 | FOLH1 |
| T52098 | DI0258 | Metabolism inborn error | [ICD-11: 5C50] | P00480 | OTC |